Regulatory July 6, 2026, 7:00 AM PT

HighVista Biotechnology Specialist Fund Files SEC Notice

HighVista Biotechnology Specialist Fund Ltd. submitted a Form D/A filing to the SEC on July 6 2026 claiming Section 3(c)(7) exemption.

Jordan Stokes

Staff Writer, PipelineRoad

HighVista Biotechnology Specialist Fund Ltd. filed a Form D/A notice with the SEC on 2026-07-06 under CIK 0001871686.

Filing Details

The filing carries accession number 0001871686-26-000001 and totals 9 KB according to SEC EDGAR.

Item 3C of the filing references Investment Company Act Section 3(c).

Item 3C.7 specifies Section 3(c)(7) according to SEC EDGAR.

Section 3(c)(7) is a widely known exemption available to certain private funds whose securities are owned exclusively by qualified purchasers.

Sources

Topics

Get capital raising signals before they hit the news.